Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders' Equity

Summary of stock option activity

				Weighted-
				Average
		Weighted-		Remaining
	Number of	Average		Contractual Life	Aggregate
	Options	Exercise Price		(in years)	Intrinsic Value
Outstanding at January 1, 2023	14,361,092	$	5.94	7.2	$	23,825
Granted	2,713,395	$	4.36
Exercised	(1,192,784)	$	1.58		$	4,106
Forfeited	(460,390)	$	9.18
Expired	(3,327)	$	6.46
Outstanding at December 31, 2023	15,417,986	$	5.90	6.9	$	15,854
Granted	1,922,756	$	4.36
Exercised	(1,191,117)	$	1.34		$	3,402
Forfeited	(2,093,840)	$	7.64
Outstanding at December 31, 2024	14,055,785	$	5.82	6.5	$	8,467
Exercisable at December 31, 2024	10,076,377	$	6.03	5.7	$	8,334

Schedule of restricted stock unit activity

				Weighted-
				Average
		Weighted-		Remaining
	Number of	Average		Amortization Period
	RSUs	Grant Date Fair Value		(in years)
Outstanding at January 1, 2023	643,600	$	5.57	3.2
Granted	1,043,150	$	4.21
Vested and released	(288,550)	$	5.48
Forfeited	(102,020)	$	4.70
Outstanding at December 31, 2023	1,296,180	$	4.57	2.8
Granted	1,280,473	$	4.36
Vested and released	(418,260)	$	4.84
Forfeited	(454,334)	$	4.48
Outstanding at December 31, 2024	1,704,059	$	4.36	2.6

Schedule of stock-based compensation expense

	Year ended December 31,
	2024		2023
General and administrative	$	7,200	$	6,114
Sales and marketing		2,920		3,252
Research and development		2,963		4,613
Total	$	13,083	$	13,979